Similar articles

• Drug essentials. The cytochrome P450 microenzyme system and targeted therapies: Minimizing drug interactions.

  Wilkes GM. Wilkes GM. Oncology (Williston Park). 2009 Feb;23(2 Suppl Nurse Ed):33, 52-6. Oncology (Williston Park). 2009. PMID: 19856586 No abstract available.
• [Genetic polymorphism of the hepatic metabolism of drugs].

  Larrey D, Pessayre D, Benhamou JP. Larrey D, et al. Gastroenterol Clin Biol. 1985 Jun-Jul;9(6-7):522-31. Gastroenterol Clin Biol. 1985. PMID: 3926587 Review. French. No abstract available.
• Polymorphism of human cytochrome P450 enzymes and its clinical impact.

  Zhou SF, Liu JP, Chowbay B. Zhou SF, et al. Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483. Drug Metab Rev. 2009. PMID: 19514967 Review.
• Current cellular assays for measuring clinical drug metabolizing capacity--impact of new molecular biologic techniques.

  Kouri RE, McLemore T, Jaiswal AK, Nebert DW. Kouri RE, et al. Prog Clin Biol Res. 1986;214:453-69. Prog Clin Biol Res. 1986. PMID: 3523516 Review. No abstract available.
• Genes and the response to drugs.

  Caraco Y. Caraco Y. N Engl J Med. 2004 Dec 30;351(27):2867-9. doi: 10.1056/NEJMe048278. N Engl J Med. 2004. PMID: 15625340 No abstract available.